The Lapis Global Medical Devices 25 Dividend Yield Index is composed of 25 worldwide best-known and leading medical device companies. All stocks in our equally weighted equity index have a market capitalization greater than USD 5 billion and 80 % of them have paid uninterrupted and continuously increasing dividends over the last 5 years. Hence, a maximum of 20 % of the companies included in our unique equity index do not apply a strict dividend payment policy and have paid their regular dividends for less than 5 years. Our rule-based criteria for selecting the most promising companies are applied during the quarterly rebalancing process (end of January, April, July, and October).

See the Factsheet and Brochure of the index for further information.